CCT245737
a CHK1 inhibitor; structure in first source
Also Known As:
5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Aherne, G Wynne:
1 article
(01/2016)
|
2. | Box, Gary:
1 article
(01/2016)
|
3. | Boxall, Kathy J:
1 article
(01/2016)
|
4. | Collins, Ian:
1 article
(01/2016)
|
5. | De Haven Brandon, Alexis K:
1 article
(01/2016)
|
6. | Eccles, Suzanne A:
1 article
(01/2016)
|
7. | Eve, Paul D:
1 article
(01/2016)
|
8. | Garrett, Michelle D:
1 article
(01/2016)
|
9. | Hayes, Angela:
1 article
(01/2016)
|
10. | Henley, Alan T:
1 article
(01/2016)
|
Related Diseases
Related Drugs and Biologics